Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?

Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?

Secondary progressive multiple sclerosis (SPMS) subtype is retrospectively diagnosed, and biomarkers of the SPMS are not available. We aimed to identify possible neurophysiological markers exploring grey matter structures that could be used in clinical practice to better identify SPMS. Fifty-five pe...

Full description

Bibliographic Details
Main Authors: Daniele Belvisi, Matteo Tartaglia, Giovanna Borriello, Viola Baione, Sebastiano Giuseppe Crisafulli, Valeria Zuccoli, Giorgio Leodori, Antonio Ianniello, Gabriele Pasqua, Patrizia Pantano, Alfredo Berardelli, Carlo Pozzilli, Antonella Conte
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
multiple sclerosis
disease progression
neurophysiology
biomarkers
transcranial magnetic stimulation
grey matter inhibitory mechanisms
Online Access:https://www.mdpi.com/2227-9059/10/2/231

Internet

https://www.mdpi.com/2227-9059/10/2/231

Similar Items